Yusuke Moritoh

10PUBLICATIONS
11CO-AUTHORS
Regenerative medicine (incl. stem cells)Characterisation of biological macromoleculesToxicology (incl. clinical toxicology)Cancer therapy (excl. chemotherapy and radiation therapy)Proteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 07, 2026
First clinical demonstration of sustained insulin-like growth factor 1 elevation via oral somatostatin receptor 5 antagonism: a phase 1 trial of SCO-240.

|Mar 29, 2024
Oral SSTR5 Antagonist SCO-240 for Growth Hormone Stimulation: A Phase I Single-Dose Study in Healthy Individuals.

Harunobu Nishizaki, Tomoya Kagawa, Jun Sugama

|Aug 12, 2021
The enzymatic activity of inositol hexakisphosphate kinase controls circulating phosphate in mammals.

Yusuke Moritoh, Shin-Ichi Abe, Hiroki Akiyama

|Jul 29, 2021
SCO-267, a GPR40 Full Agonist, Stimulates Islet and Gut Hormone Secretion and Improves Glycemic Control in Humans.

Harunobu Nishizaki, Osamu Matsuoka, Tomoya Kagawa

|Feb 06, 2021
Chronic Exposure to SCO-267, an Allosteric GPR40 Full Agonist, Is Effective in Improving Glycemic Control in Rats.

Ryokichi Koyama, Mitsugi Ookawara, Masanori Watanabe

|Sep 07, 2020
Enteropeptidase inhibition improves kidney function in a rat model of diabetic kidney disease.

Jun Sugama, Yuko Katayama, Yusuke Moritoh

Pageof 2

Frequent Collaborators

4 joint publications

Masanori Watanabe

2 joint publications

Jun Sugama

2 joint publications

Akihiro Kobayashi

1 joint publications

Masako Sasaki